tiprankstipranks
Advertisement
Advertisement

BMY Stock Latest News

BMY Advances Early Brain-Targeted Asset With New PET Imaging Study
Company AnnouncementsBMY Advances Early Brain-Targeted Asset With New PET Imaging Study
2d ago
BMY
Bristol Myers price target lowered to $66 from $67 at BofA
PremiumThe Fly
Bristol Myers price target lowered to $66 from $67 at BofA
2d ago
BMY
AI Daily: Amazon’s AWS commits $1B toward new unit
PremiumThe Fly
AI Daily: Amazon’s AWS commits $1B toward new unit
12d ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
PremiumThe Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
12d ago
AZN
BMY
The Week That Was, The Week Ahead: Macro and Markets, June 28
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, June 28
14d ago
A
O
Bristol-Myers Squibb Advances Japanese Real-World Study of Mavacamten in Hypertrophic Cardiomyopathy
PremiumCompany AnnouncementsBristol-Myers Squibb Advances Japanese Real-World Study of Mavacamten in Hypertrophic Cardiomyopathy
16d ago
BMY
3 Best ETFs AI Analyst Recommends — June 22, 2026
Premium
Market News
3 Best ETFs AI Analyst Recommends — June 22, 2026
20d ago
VZ
BMY
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
Premium
Company Announcements
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
24d ago
BMY
Bristol-Myers Squibb’s Real World Kidney Cancer Study Signals Durable Immunotherapy Momentum
PremiumCompany Announcements
Bristol-Myers Squibb’s Real World Kidney Cancer Study Signals Durable Immunotherapy Momentum
26d ago
BMY
J&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital
PremiumThe Fly
J&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital
27d ago
BMY
JNJ
CMS proposes to lock in lower prices in Medicare drug price negotiation program
PremiumThe Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
27d ago
AZN
BMY
Bristol-Myers Squibb Advances Phase 1 Liver Study for New Drug BMS-986435
PremiumCompany Announcements
Bristol-Myers Squibb Advances Phase 1 Liver Study for New Drug BMS-986435
1M ago
BMY
Bristol-Myers Squibb’s Mavacamten Study Signals Real‑World Momentum in Heart Drug Market
PremiumCompany AnnouncementsBristol-Myers Squibb’s Mavacamten Study Signals Real‑World Momentum in Heart Drug Market
1M ago
BMY
Heart-Disease Biotech Kardigan Set For $1.4B U.S. IPO
Premium
Market News
Heart-Disease Biotech Kardigan Set For $1.4B U.S. IPO
1M ago
BMY
JEF
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
1M ago
AZN
BMY
Bristol-Myers Squibb: Emerging Oncology Portfolio Supports Durable Growth; Buy Rating Reiterated with Unchanged $70 Price Target
PremiumRatings
Bristol-Myers Squibb: Emerging Oncology Portfolio Supports Durable Growth; Buy Rating Reiterated with Unchanged $70 Price Target
1M ago
BMY
Arcus enters clinical trial collaboration, supply agreement with Bristol Myers
PremiumThe Fly
Arcus enters clinical trial collaboration, supply agreement with Bristol Myers
1M ago
BMY
RCUS
Bristol-Myers Squibb’s Italian Anticoagulant Study: Real-World Signals for BMY Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s Italian Anticoagulant Study: Real-World Signals for BMY Investors
1M ago
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
1M ago
AZN
BMY
Bristol Myers, SystImmune announce results from analyses of iza-bren studies
PremiumThe FlyBristol Myers, SystImmune announce results from analyses of iza-bren studies
1M ago
BMY
Bristol Myers: Opdivo in combination with AVD receives expanded EU label
Premium
The Fly
Bristol Myers: Opdivo in combination with AVD receives expanded EU label
1M ago
BMY
Bristol Myers says FDA accepts sNDA for Camzyos
Premium
The Fly
Bristol Myers says FDA accepts sNDA for Camzyos
1M ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >